{
  "id": "55031628e9bde69634000024",
  "type": "list",
  "question": "Which neuroendocrine tumors are associated with specific tumor syndromes?",
  "ideal_answer": "Neuroendocrine tumors are a heterogeneous group of benign and malignant neoplasias, detectable in the context of hereditary tumor syndromes in up to 30% of cases. Neuroendocrine tumors include medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23010473",
    "http://www.ncbi.nlm.nih.gov/pubmed/22041710",
    "http://www.ncbi.nlm.nih.gov/pubmed/19708762",
    "http://www.ncbi.nlm.nih.gov/pubmed/21181474",
    "http://www.ncbi.nlm.nih.gov/pubmed/14685672"
  ],
  "snippets": [
    {
      "text": "Pheochromocytomas are neuroendocrine tumors of the adrenal medulla which can occur either sporadically or in the context of hereditary tumor syndromes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23010473",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors of the adrenal glands and the sympathetic and parasympathetic paraganglia. They can occur sporadically or as a part of different hereditary tumor syndromes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22041710",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Pancreatic neuroendocrine tumors (PNETs) are a characteristic feature of the tumor syndromes multiple endocrine neoplasia type 1 (MEN-1) and von Hippel-Lindau disease (VHL)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21181474",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This review focuses on hereditary syndromes with neuroendocrine tumors, including multiple endocrine neoplasia types 1 and 2, Von Hippel-Lindau disease, neurofibromatosis type 1, Carney complex, pheochromocytoma-paraganglioma syndrome, and familial nonmedullary thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma, emphasizing specific histopathologic characteristics",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19708762",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Neuroendocrine tumors (NETs) are a heterogeneous group of benign and malignant neoplasias, detectable in the context of hereditary tumor syndromes in up to 30% of cases",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14685672",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "RET gene analysis can identify individuals with a very high risk to develop familial medullary cancer (MEN2)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14685672",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma, emphasizing specific histopathologic characteristics",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19708762",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.disease-ontology.org/api/metadata/DOID:169"
  ],
  "exact_answer": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, paraganglioma"
}